The quality of life after keratinized mucosa augmentation around dental implants using xenogenic collagen matrix with or without stent.

BACKGROUND: The substitution of missing teeth with implants is a dependable and anticipated therapeutic approach. Despite numerous studies affirming long-term success rates, there exists a spectrum of potential biological and aesthetic complications. OBJECTIVE: The primary objective of this study was to assess patient responses subsequent to surgical interventions, with a specific emphasis on the utilization of xenogenic collagen matrix (XCM), both with and without the application of a stent secured over healing abutments, in the context of keratinized gingival mucosa augmentation. The principal aim was to evaluate and draw comparisons between the clinical outcomes resulting from these two procedural approaches, with a particular focus on critical parameters encompassing post-operative complications, patient comfort, and the overall efficacy in achieving successful keratinized tissue augmentation. methods: Sixty patients were selected for this study. The patients were divided into three groups: A, B, and a control group, with each group comprising 20 participants. We used XCM in experimental group A, XCM covered with surgical stent in experimental group B, and free gingival graft (FGG) in the control group. After the surgical procedure, patients were required to complete a visual analogue scale (VAS) questionnaire for post-operative complications, and a quality of life (QOL) questionnaire on days 1, 3, and 7. RESULTS: Patients in the experimental groups A and B demonstrated markedly improved outcomes when compared with the control group. Assessments conducted on days 1, 3, and 7 demonstrated diminished levels of pain, bleeding, and swelling in both experimental groups, with experimental group B showing the least discomfort. The incorporation of XCM, either with or without stents, was associated with a reduction in analgesic consumption, underscoring its favorable influence on post-operative comfort, notwithstanding the exception of halitosis in experimental group B. CONCLUSION: Using XCM with or without a stent for keratinized tissue augmentation has better post-operative outcomes associated with reduced swelling, bleeding, and pain based on the QOL survey. This study provides data to support the clinical application of XCM and stents.

[Characterization and Health Risk of Heavy Metals in PM2.5 from Road Fugitive Dust in Five Cities of Yunnan Province].

In order to study the contents, sources, and health risk of PM2.5 in road fugitive dust in Yunnan, road fugitive dust samples were collected from five typical cities including Kunming, Baoshan, Wenshan, Zhaotong, and Yuxi. Particulate matter resuspension technology was used to levitate the dust samples and collect PM2.5. Eight heavy metals including chromium (Cr), manganese (Mn), nickel (Ni), copper (Cu), zinc (Zn), selenium (As), cadmium (Cd), and lead (Pb) in PM2.5 were detected using ICP-MS. The results showed that the contents of Cr, Ni, Cu, Zn, and Pb in road fugitive dust seriously exceeded the background values of Yunnan soil. The enrichment factors showed that most of the heavy metals in PM2.5 of road fugitive dust in the five cities of Yunnan were moderately enriched and strongly enriched, which were greatly influenced by human activities. The results of correlation analysis and principal component analysis showed that the heavy metals in PM2.5 of road fugitive dust in Yunnan were all affected by soil and traffic sources. The other sources varied greatly in different cities:Kunming was affected by iron and steel melting sources, Baoshan and Yuxi were affected by non-ferrous metal smelting sources, and Zhaotong was affected by coal sources. Health risk analysis showed that Cr, Pb, and As in road fugitive dust PM2.5 had non-carcinogenic risk in children in Kunming, Yuxi, and Zhaotong, respectively, and Cr in Kunming also had a lifetime carcinogenic risk.

Mega-oss and Mega-TCP versus Bio-Oss granules fixed by alginate gel for bone regeneration.

OBJECTIVES/AIMS: Bone graft materials are widely used at present because inadequate bone volume is usually found in implant patients. To determine the biocompatibility of a new grafting material, in vitro research is routinely performed before animal experiments and clinical testing. However, during in vitro experiments, bone material particles might move during testing, which could affect the accuracy of the results. MATERIALS AND METHODS: To evaluate the biocompatibility of new bone substitutes, Mega-oss and Mega-TCP were compared with Bio-Oss using osteoblast cells and osteoclast cells fixed with alginate gel. Cell morphology, viability, bone resorption, alkaline phosphatase (ALP) activity, and staining were tested to compare the biocompatibility differences in the performance of Mega-oss, Mega-TCP, and Bio-Oss. RESULTS: Cells spread better on Mega-oss and Mega-TCP than the round shape on Bio-Oss. The 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) results showed that Mega-oss, Mega-TCP, and sodium alginate had good viability. Meanwhile, Mega-oss and Mega-TCP had the same osteoblast differentiation ability as Bio-Oss. The resorption rates of Mega-TCP and Mega-oss were higher than those of Bio-Oss (24.4%, 15.3%, and 3.3%, respectively). CONCLUSION: Mega-oss and Mega-TCP might be useful alternative bone graft materials compared with Bio-Oss. In addition, fixing the materials with sodium alginate gel could be a new method for in vitro bone material experiments.